LSTA Lisata Therapeutics, Inc.
Healthcare$3.20+1.91%ClosedMarket Cap: $29.1M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
2.59
P/S
168.20
EV/EBITDA
-0.92
DCF Value
$1.92
FCF Yield
-47.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
98.8%
Operating Margin
-10178.2%
Net Margin
-9618.2%
ROE
-101.9%
ROA
-116.3%
ROIC
-157.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-4.9M | $-4.5M | $— | — |
| Q4 null | $100.0K | 100.0% | $-3.1M | $-3.0M | $— | — |
| FY null | $170.0K | 14.1% | $-18.2M | $-16.6M | $— | — |
| Q3 null | $0.00 | NaN% | $-4.4M | $-4.2M | $— | — |
| Q2 null | $70.0K | 100.0% | $-4.9M | $-4.7M | $— | — |
| Q1 null | $0.00 | NaN% | $-5.8M | $-4.7M | $— | — |
| Q4 null | $1.0M | 100.0% | $-4.9M | $-4.6M | $— | — |
| FY null | $1.0M | 100.0% | $-22.4M | $-20.0M | $— | — |
| Q3 null | $0.00 | NaN% | $-5.3M | $-4.9M | $— | — |
| Q2 null | $0.00 | NaN% | $-5.5M | $-5.0M | $— | — |
| Q1 null | $0.00 | NaN% | $-6.6M | $-5.4M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-6.0M | $-5.4M | $-0.66 | — |